Rohan Katipally to Neoplasms
This is a "connection" page, showing publications Rohan Katipally has written about Neoplasms.
Connection Strength
1.007
-
Nontumor Cells in Tumor Samples Bias Expression-Based Models-Reply. JAMA Oncol. 2024 02 01; 10(2):260-261.
Score: 0.269
-
Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal Transition. Clin Cancer Res. 2023 08 01; 29(15):2761-2766.
Score: 0.260
-
The oligometastatic spectrum in the era of improved detection and modern systemic therapy. Nat Rev Clin Oncol. 2022 09; 19(9):585-599.
Score: 0.242
-
Longitudinal Associations Between Financial Toxicity and Health-Related Quality of Life for Patients With Cancer. JCO Oncol Pract. 2026 Apr; 22(4):675-685.
Score: 0.074
-
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy. Med. 2023 12 08; 4(12):863-874.
Score: 0.067
-
Metastasis. Cancer Cell. 2022 08 08; 40(8):787-791.
Score: 0.061
-
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. Eur J Cancer. 2024 Sep; 209:114264.
Score: 0.017
-
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease. J Clin Oncol. 2024 10 10; 42(29):3387-3391.
Score: 0.017